Polycythemia, SGLT2 inhibitors, and associated outcomes across the cardio-kidney-metabolic spectrum: a pooled analysis of randomized trials. - Marques P; Vasques-Nóvoa F; Pintalhão M; Bergantim R; Mendonça L; Neves JS; Friões F; Sharma A; Filipatos G; Butler J; Anker S; Zannad F; et al. (European journal of internal medicine, 2026)